Le, H., Ryan, K., Wahlstrom, S. K., Pendergraft, T., Maculaitis, M. C., Will, O., … LeBlanc, T. W. (2020). Patient and physician decision-making on the use of novel agents in chronic lymphocytic leukemia (CLL): What drives preferences? In JOURNAL OF CLINICAL ONCOLOGY (Vol. 38).

Le, Hannah, Kellie Ryan, Svea K. Wahlstrom, Trudy Pendergraft, Martine C. Maculaitis, Oliver Will, Emily Mulvihill, and Thomas William LeBlanc. “Patient and physician decision-making on the use of novel agents in chronic lymphocytic leukemia (CLL): What drives preferences?” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 38, 2020.

Le H, Ryan K, Wahlstrom SK, Pendergraft T, Maculaitis MC, Will O, et al. Patient and physician decision-making on the use of novel agents in chronic lymphocytic leukemia (CLL): What drives preferences? In: JOURNAL OF CLINICAL ONCOLOGY. 2020.

Le, Hannah, et al. “Patient and physician decision-making on the use of novel agents in chronic lymphocytic leukemia (CLL): What drives preferences?” JOURNAL OF CLINICAL ONCOLOGY, vol. 38, no. 29, 2020.

Le H, Ryan K, Wahlstrom SK, Pendergraft T, Maculaitis MC, Will O, Mulvihill E, LeBlanc TW. Patient and physician decision-making on the use of novel agents in chronic lymphocytic leukemia (CLL): What drives preferences? JOURNAL OF CLINICAL ONCOLOGY. 2020.